Article Information
History
- March 2, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Vidya Menon, MD, FACP*,1,
- Masood A Shariff, MD1,
- Victor Perez Gutierrez, MD1,
- Juan M Carreño, PhD2,
- Bo Yu, MD1,
- Muzamil Jawed, DO1,
- Marcia Gossai, MD1,
- Elisenda Valdez, MD1,
- Anjana Pillai, MD1,
- Usha Venugopal, MD1,
- Moiz Kasubhai, MD1,
- Vihren Dimitrov, MD1 and
- Florian Krammer, PhD2
- 1Department of Medicine, NYC Health + Hospitals/Lincoln, The Bronx, NY
- 2Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY
- ↵*Corresponding Author: Vidya Menon, MD, FACP, NYC HHC/Lincoln, 234 E 149th Street, The Bronx, New York 10451, Email: menonv{at}nychhc.org, Phone: 718-579-5000 ext. 3485
Posted March 02, 2021.
High Initial Titres of Anti-Spike Antibodies following SARS-CoV-2 Infection is Associated with Faster Decay Rates at Four Months Follow-Up
